|
🐜
|
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
34 auth.
D. Lambrechts,
E. Storkebaum,
M. Morimoto,
J. Del-Favero,
F. Desmet,
S. Marklund,
S. Wyns,
V. Thijs,
Jörgen Andersson,
I. V. Marion,
A. Al-Chalabi,
S. Bornes,
R. Musson,
Valerie K. Hansen,
L. Beckman,
...
R. Adolfsson,
H. Pall,
H. Prats,
S. Vermeire,
P. Rutgeerts,
S. Katayamá,
T. Awata,
N. Leigh,
L. Lang-Lazdunski,
M. Dewerchin,
C. Shaw,
L. Moons,
R. Vlietinck,
K. Morrison,
W. Robberecht,
C. Broeckhoven,
D. Collen,
P. Andersen,
P. Carmeliet
|
9 |
2003 |
9
🐜
|
|
🦁
|
Core Text of Neuroanatomy
N. Leigh
|
8 |
1986 |
8
🦁
|
|
🐢
|
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
11 auth.
Richard G. Brown,
L. Lacomblez,
B. Landwehrmeyer,
T. Bak,
I. Uttner,
B. Dubois,
...
Y. Agid,
A. Ludolph,
G. Bensimon,
C. Payan,
N. Leigh
|
8 |
2010 |
8
🐢
|
|
🐜
|
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis
57 auth.
Bradley N. Smith,
S. Topp,
C. Fallini,
H. Shibata,
Han-Jou Chen,
C. Troakes,
A. King,
N. Ticozzi,
K. Kenna,
Athina Soragia-Gkazi,
Jack W. Miller,
Akane Sato,
Diana Marques Dias,
M. Jeon,
C. Vance,
...
C. Wong,
M. Majo,
Wejdan Kattuah,
Jacqueline C Mitchell,
Emma L. Scotter,
Nicholas W Parkin,
P. Sapp,
M. Nolan,
P. Nestor,
M. Simpson,
M. Weale,
M. Lek,
M. Lek,
F. Baas,
J. D. Jong,
A. T. Asbroek,
Alberto G Redondo,
J. Esteban-Pérez,
C. Tiloca,
F. Verde,
S. Duga,
N. Leigh,
H. Pall,
K. Morrison,
A. Al-Chalabi,
P. Shaw,
J. Kirby,
M. Turner,
K. Talbot,
O. Hardiman,
J. Glass,
J. Belleroche,
M. Maki,
S. Moss,
Christopher C. J. Miller,
C. Gellera,
A. Ratti,
S. Al-Sarraj,
Robert H. Brown,
V. Silani,
J. Landers,
C. Shaw
|
7 |
2017 |
7
🐜
|
|
🐢
|
Clinical care of patients with amyotrophic lateral sclerosis
A. Radunović,
H. Mitsumoto,
N. Leigh
|
7 |
2007 |
7
🐢
|
|
🐜
|
An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62‐positive, TDP‐43‐negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline
17 auth.
C. Troakes,
S. Maekawa,
L. Wijesekera,
B. Rogelj,
L. Siklós,
C. Bell,
Bradley N. Smith,
S. Newhouse,
C. Vance,
L. Johnson,
...
T. Hortobágyi,
A. Shatunov,
A. Al-Chalabi,
N. Leigh,
C. Shaw,
A. King,
S. Al-Sarraj
|
7 |
2012 |
7
🐜
|
|
🐜
|
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.
65 auth.
I. Fogh,
A. Ratti,
C. Gellera,
Kuang Lin,
C. Tiloca,
V. Moskvina,
L. Corrado,
G. Soraru',
Cristina Cereda,
S. Corti,
D. Gentilini,
D. Calini,
B. Castellotti,
L. Mazzini,
G. Querin,
...
S. Gagliardi,
R. del Bo,
F. Conforti,
G. Siciliano,
Maurizio Inghilleri,
F. Saccà,
P. Bongioanni,
S. Penco,
M. Corbo,
S. Sorbi,
M. Filosto,
A. Ferlini,
A. Di Blasio,
S. Signorini,
A. Shatunov,
Ashley Jones,
P. Shaw,
K. Morrison,
A. Farmer,
P. van Damme,
W. Robberecht,
A. Chiò,
B. Traynor,
M. Sendtner,
J. Melki,
V. Meininger,
O. Hardiman,
P. Andersen,
N. Leigh,
J. Glass,
Daniel Overste,
F. Diekstra,
J. Veldink,
M. V. van Es,
C. Shaw,
M. Weale,
C. Lewis,
Julie Williams,
Robert H. Brown,
J. Landers,
N. Ticozzi,
M. Ceroni,
E. Pegoraro,
G. Comi,
S. D'alfonso,
L. H. van den Berg,
F. Taroni,
A. Al-Chalabi,
J. Powell,
V. Silani
|
6 |
2014 |
6
🐜
|
|
🐜
|
Phase II/III randomized trial of TCH346 in patients with ALS
47 auth.
Robert G. Miller,
Walter G. Bradley,
M. Cudkowicz,
J. Hubble,
V. Meininger,
H. Mitsumoto,
Darlene Moore,
H. Pohlmann,
D. Sauer,
V. Silani,
M. Strong,
M. Swash,
E. Vernotica,
N. Cashman,
A. Eisen,
...
C. Krieger,
A. Genge,
S. Kalra,
J. Turnbull,
L. Lacomblez,
W. Camu,
A. Destée,
A. Ludolph,
R. Dengler,
T. Meyer,
A. Chiò,
L. Berg,
M. Visser,
F. Vingerhoets,
O. Hardiman,
N. Leigh,
J. Shefner,
W. David,
M. Graves,
T. Heiman-Patterson,
H. Neville,
J. Rosenfeld,
M. Bromberg,
A. Corse,
A. Waclawik,
E. Pioro,
R. Sufit,
S. Appel,
R. Pascuzzi,
J. Kissel,
C. Jackson,
R. Barohn
|
6 |
2007 |
6
🐜
|
|
🐜
|
Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial
30 auth.
C. Mcdermott,
M. Bradburn,
Chin Maguire,
C. Cooper,
Wendy O Baird,
S. Baxter,
S. Bourke,
I. Imam,
A. Bentley,
J. Ealing,
M. Elliott,
C. Hanemann,
P. Hughes,
R. Orrell,
P. Shaw,
...
K. Talbot,
T. Williams,
R. Ackroyd,
R. Berrisford,
S. Galloway,
D. Karat,
N. Maynard,
A. Sarela,
A. Simonds,
L. Taylor,
R. Leek,
R. Darlison,
N. Leigh,
M. Dewey,
A. Radunović
|
6 |
2015 |
6
🐜
|
|
🐬
|
Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis
M. Polkey,
R. Lyall,
Ke Yang,
E. Johnson,
N. Leigh,
J. Moxham
|
6 |
2017 |
6
🐬
|
|
🐜
|
Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the −2578AA genotype
24 auth.
D. Lambrechts,
K. Poesen,
R. Fernández-Santiago,
A. Al-Chalabi,
R. Bo,
P. V. Vught,
S. Khan,
S. Marklund,
A. Brockington,
I. V. Marion,
...
J. Anneser,
Christopher E Shaw,
A. Ludolph,
N. Leigh,
G. Comi,
T. Gasser,
P. Shaw,
K. Morrison,
P. Andersen,
L. H. Berg,
Vincent Thijs,
T. Siddique,
W. Robberecht,
P. Carmeliet
|
6 |
2008 |
6
🐜
|
